Exenatide

Specifications

141758-74-9CAS Number

686-356-3EC Number

(4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2IUPAC Name

C184H282N50O60SChemical Formula

4187 g/molMolecular Weight

Exenatide; 141758-74-9; Bydureon Pen; Byetta; Bydureon; Exendin 4; PT302; LY2148568; 9P1872D4OL; exenatidum; AC2993A; Ex4 peptide; AC002993; DTXSID9040475; CHEBI:64073; Peptide, Ex4; BYDUREON BCISE; RefChem:58251; A10BJ01; DTXCID001323055; His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2; AC-002993; AC-2993; AC-2993A; AC-2993LAR; AC2993; DA-3091; exenatida; Exendin 4 (Heloderma suspectum); ITCA-650; L-Serinamide, L-histidylglycyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-leucyl-L-seryl-L-lysyl-L-glutaminyl-L-methionyl-L-alpha-glutamyl-L-alpha-glutamyl-L-alpha-glutamyl-L-alanyl-L-valyl-L-arginyl-L-leucyl-L-phenylalanyl-L-isoleucyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-lysyl-L-asparaginylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-alanyl-L-prolyl-L-prolyl-L-prolyl-; LY-2148568; Exenatide Synthetic; C184H282N50O60S; AC 2993; UNII-9P1872D4OL; ITCA 650; HSDB 7789; Exenatide [USAN:INN:BAN:JAN]; AC 2993A; DA 3091; Exenatide acetate salt; Exendin-4 (Standard); LY 2148568; orb1303499; SCHEMBL14634818; (Ser-39 = C-terminal amide); GLXC-22467; HB3157; HY-13443R; AKOS015994651; FE31731; HS-2012; DA-63338; E9417; HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS; Exendin 3 (Heloderma horridum), 2-glycine-3-L-glutamic acid-Synonyms